Aegis Ventures

Aegis Ventures is a New York-based venture studio and investor with a distinctive operating model: they co-found and incubate companies, often in partnership with major health systems and academic medical centers, and back external founders selectively. The fund has a meaningful healthcare focus, with public deals across digital health, clinical AI, and provider-facing tools, frequently launched in collaboration with health system partners that provide clinical validation, data, and pilot footprint. For AI founders building products that touch hospital operations, clinical workflow, diagnostics, or population health, Aegis is a serious counterparty because they bring distribution and clinical validation, not just capital. Stage is typically seed and Series A, with check sizes plausibly $1M to $10M depending on whether they are leading or following. Founders who should approach: clinical AI teams with a thesis that requires deep health system integration — care management, ambient documentation, decision support, operations, throughput, or post-acute coordination — particularly if you can articulate why a health system partnership accelerates your product roadmap. Founders who should not approach: consumer-direct health apps with no provider integration, pure biotech, and early-stage teams without clinical advisors who can credibly stand up a pilot. The entry path is warm introduction through their health system partners, the founders they have co-built with, or the broader NYC digital-health network. Be prepared to discuss what specific health system relationship you would unlock through a partnership, because that is core to their model. Their LinkedIn lists partners and portfolio that map the network for outreach.